Biosimilars

  decision foresight.png

Global Biosimilars Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030


A biosimilar, which is also known as biologic is an official version of the original "innovator" product that is similar to another already approved biological medicine. Biosimilars are approved drugs that have the same standards of pharmaceutical quality, safety and efficacy that apply to all biological medicines. Biosimilars are generally manufactured when the original medicine patent gets expired or about to expire. These newly developed drugs are less expensive in comparison to the original drugs and may have minor differences in clinically inactive components. Biosimilars are mostly used for the treatment of areas such as oncology, diabetes, and others. These drugs have a favorable market growth due to the rise in the geriatric population, rising of chronic diseases and approval by government authorities. The global biosimilars market was valued at USD 27425.3 billion in 2020 and is expected to be valued at USD 1506124.8 billion by 2030, with an approximate CAGR of 49% during the forecasted period.

Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Table & Figures) @ https://www.decisionforesight.com/request-sample/DFS020175

Market Dynamics and Factors:

Owing to the growing demand for pharmaceutical drugs, the expiration of major patents drugs are the factors that are driving the market. However, market growth is restraint due to the high cost of reference products and reimbursement service providers. Reasonable return of investment with the continued attractiveness of R&D investment in new medicines development will allow the growth of the market. Furthermore, the biosimilar market growth will be a challenge due to the lack of regulatory guidelines, consumers brand preferences, the reluctance of physicians to prescribed biosimilars and the high capital required for research and development.

Market Segmentation:

  • Global Biosimilars Market – By Product

    • Insulin

    • Interferon

    • Etanercept

    • Infliximab

    • Rituximab

    • Glucagon

    • Calcitonin

  • Global Biosimilars Market – By Application

    • Oncology

    • Chronic Disease

    • Blood Disorder

    • Autoimmune Disease

    • Growth Hormone Deficiency

  • Global Biosimilars Market – By Geography

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • U.K.

      • France

      • Germany

      • Italy

      • Rest of Europe

    • Asia-Pacific

      • Japan

      • China

      • India

      • Australia

      • Rest of Asia Pacific

    • ROW

      • Latin America

      • Middle East

      • Africa

New Business Strategies, Challenges & Policies are mentioned in Table of Content, Request TOC at @ https://www.decisionforesight.com/toc-request/DFS020175 

Geographic Analysis:

North America accounted for the largest share in terms of the revenue, accounting for approximately 30% of the global market, in 2019. The growth in this region is mainly driven by the presence of many large research laboratories, such as Sandoz, Amgen, Teva Pharmaceutical, and others. According to a research study, about 40 biosimilars are under development, which includes approximately 20 biosimilars ready to be released in market, and a noteworthy number of biosimilars are in the pipeline. Attributed to the immense economic developments and growing biotechnology companies in the region, Asia-Pacific is also expected to record robust growth over the forecast period. Additionally, factors such as high demand for the low-cost therapeutics and treatments, increase in R&D expenditures by the market players in the emerging economies such as India, South Korea, and China, and high prevalence and incidence of various chronic diseases, are also propelling the growth of biosimilars market in the Asia Pacific region.

Competitive Scenario:

Some of the major players of the market include Pfizer Inc., Sandoz International GmbH, Biocon Ltd., Dr. Reddy’s Laboratories Ltd., Amgen Inc., Teva Pharmaceuticals Inc., Celltrion Inc., Samsung Bioepis, Samsung Biologics, Gan & Lee Pharmaceuticals, and Gedeon Richter.

Connect to Analyst @ https://www.decisionforesight.com/speak-analyst/DFS020175 

How will this Market Intelligence Report Benefit You?

  1. The report offers statistical data in terms of value (US$) as well as Volume (units) till 2030.

  2. Exclusive insight into the key trends affecting the Global Biosimilars industry, although key threats, opportunities and disruptive technologies that could shape the Global Biosimilars Market supply and demand.

  3. The report tracks the leading market players that will shape and impact the Global Biosimilars Market most.

  4. The data analysis present in the Global Biosimilars Market report is based on the combination of both primary and secondary resources.

  5. The report helps you to understand the real effects of key market drivers or retainers on Global Biosimilars Market business.

The 2021 Annual Global Biosimilars Market offers:

  • 100+ charts exploring and analysing the Global Biosimilars Market from critical angles including retail forecasts, consumer demand, production and more

  • 15+ profiles of top producing states, with highlights of market conditions and retail trends

  • Regulatory outlook, best practices, and future considerations for manufacturers and industry players seeking to meet consumer demand

  • Benchmark wholesale prices, market position, plus prices for raw materials involved in Global Biosimilars Market type

Buy This Premium Research Report@ https://www.decisionforesight.com/checkout/DFS020175 

About Us:

Decision Foresight is a market research organization known for its reliable and genuine content, market estimation and the best analysis which is designed to deliver state-of-the-art quality syndicate reports to our customers. Apart from syndicate reports, you will find the best market insights, strategies that will help in taking better business decisions on subjects that may require you to develop and grow your business-like health, science, technology and many more. At Decision Foresight, we truly believe in disseminating the right piece of knowledge to a large section of the audience and cover the in-depth insights of market leaders across various verticals and horizontals.

Contact:

Email: sales@decisionforesight.com

For Latest Update Follow Us:

https://www.facebook.com/Decision-Foresight-110793387201935

https://twitter.com/DecisionFs

https://www.linkedin.com/company/decision-foresight/

Comments

Post a Comment

Popular posts from this blog

Digital Pathology

Image
  Global Digital Pathology Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 Global Digital Pathology Market accounted USD 721.7 million in 2020 and is anticipated to reach USD 2281.7469 million by 2030, at a CAGR of 12.2% during the forecast period. It is an innovation predominantly committed to minimize laboratory expenses, increase operational efficiency, improving treatment decisions and patient care, and improved overall productivity. This technique incorporates the management, acquisition, sharing and interpretation of pathology information — which include slides and data — in a digital environment. Digital slides are produced when glass slides are apprehended with a scanning device, to deliver a high-resolution digital image that can be observed on a computer screen or mobile device. Virtual microscopy is a part of the market which enables to practice converting glass slides into digital slides that can be viewed, managed, shared and analyzed on a computer m...
Read more

Global Antisense And RNAi Therapeutics Market

Image
  Global Antisense And RNAi Therapeutics Market Size, Share, Growth, Industry Trends and Forecast 2020-2030 Antisense and RNAi therapeutics are therapeutic treatments having the potential to treat diseases such as chronic liver and cardiovascular diseases, and other rare diseases. Antisense RNAi was the largest technology segment in 2018 due to technological advancement in the healthcare sector. Antisense technology is a method that can stop protein production. Antisense technology can be used to design new therapeutics for certain new diseases. The principle behind is antisense nucleic acid sequence base pairs with complementary sense RNA strand and avoids from being translated into a protein. Based on the triggering of the RNA molecules this technology is segmented into siRNA and miRNA. Antisense and RNAi therapeutics services are applicable in the treatment of a wide range of diseases that target nucleic acid and affect the cell growth cycle. miRNA has the ability to restore gen...
Read more

Regenerative Therapies

Image
  Global Regenerative Therapies Market Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts to 2030 The Global regenerative therapies market held USD 8.5 billion in 2020 and is to grow with a CAGR of 15.7% from 2020-2030. Regenerative medicine is medicine principle that focuses on the replacement of tissues, human cells and organs in order to restore normal functionality. Regenerative medicine aims to renew or replace cells in the damaged and unfitting tissue or organ of human beings. The body's own cells can be encouraged to cure, or a patient with laboratories-grown cells and tissues can be therapied. It can treat incurable chronic disorders and conditions such as Alzheimer's disease, Parkinson's disease, diabetes, cardiac illness, kidney failure, osteoporosis and injuries to the spinal cord, etc. Download Sample Copy of the Report to understand the structure of the complete report (Including Full TOC, Tabl...
Read more